IBM
81
3
DTE
63
7
TGNA
48
-2
NKE
46
12
T
56
2
ED
53
4
UA
32
8
FLR
52
4
ADI
59
-2
SO
66
2
DE
53
8
ISRG
68
-3
USB
44
-3
FAST
46
-3
MAT
51
-3
WFC
63
3
CAG
46
10
UNH
53
-3
AMP
66
-4
DUK
64
2
IBM
81
3
DTE
63
7
TGNA
48
-2
NKE
46
12
T
56
2
ED
53
4
UA
32
8
FLR
52
4
ADI
59
-2
SO
66
2
DE
53
8
ISRG
68
-3
USB
44
-3
FAST
46
-3
MAT
51
-3
WFC
63
3
CAG
46
10
UNH
53
-3
AMP
66
-4
DUK
64
2
Financhill
Back

Newmont Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
50

NGT.TO
Newmont

Last Price:
73.81
Seasonality Move:
0.54%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
50
Newmont (NGT.TO) is a Sell

Is Newmont a Buy, Sell or Hold?

  • The current Newmont [NGT.TO] share price is $73.81. The Score for NGT.TO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • NGT.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NGT.TO Stock Price Chart

What is Newmont's stock price today?

  • The Newmont share price today is $73.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NGT.TO is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

NGT.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.39 Buy
Relative Strength Index (14 RSI): 65.75 Buy
Chaikin Money Flow: 34127 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.34 - 72.18) Buy
Bollinger Bands (100): (57.1 - 68.72) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

NGT.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.11 Buy
20-day SMA: 70.98 Buy
50-day SMA: 68.26 Buy
200-day SMA: 56.11 Buy
8-day EMA: 72.21 Buy
20-day EMA: 70.93 Buy
50-day EMA: 67.93 Buy
200-day EMA: 59.87 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Newmont Earnings Growth & NGT.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.66 per share, an increase next quarter of $0.15 per share, an increase this year of $2.04 per share, and an increase next year of $0.84 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Newmont Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):